Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John R. Stuelpnagel currently holds 344,250 shares of 10x Genomics, Inc. (TXG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John R. Stuelpnagel has been a net seller of TXG stock. They have purchased $0 and sold $48.1M worth of shares.
John R. Stuelpnagel's most recent insider trade was on Jun 11, 2024, when they sold 8,649 shares at $0.00 per share.
John R. Stuelpnagel serves as Executive at 10x Genomics, Inc. (TXG). They have executed 236 insider transactions totaling $48.1M over their tenure at the company.
John R. Stuelpnagel holds the position of Executive at 10x Genomics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John R. Stuelpnagel has shown a selling trading pattern, with $0 in total purchases and $48.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John R. Stuelpnagel was on Oct 7, 2021, when they sold $750.9K worth of TXG shares. This transaction involved 5,000 shares at $150.18 per share.
John R. Stuelpnagel currently owns 344,250 shares of 10x Genomics, Inc. (TXG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John R. Stuelpnagel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John R. Stuelpnagel has 236 Form 4 filings on record as an insider at 10x Genomics, Inc..
Set alerts for John R. Stuelpnagel and 40,000+ other insiders.